🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Amazing ASCO poster Duaa Kanan, MD!!!

Amazing to share the #HearHer campaign with these amazing patient advocates today here at ASCO . We are inspired by all of you and have learned tremendously from our discussions. We are so thankful to share with you all! There’s still time to get your pin!!!

So glad to finally meet Alex Chan, PharmD, MPH in person at #ASCO25! A great leader and collaborator — excited about the impactful projects we’re working on together at MASCC Enrique Soto

Dr. Luis Paz-Ares brings small cell lung cancer to the center stage here at #ASCO25– results of phase 3 IMforte! ASCO OncoAlert LungCancerRx 🫁💊

🎉 Huge congrats to friend and colleague Dr. Maria Velez Maria Antonia Vélez on her powerful #ASCO25 poster shedding light on a hidden survivorship challenge: post-ICI thyroid dysfunction 🧬🛑 📊 In >3,600 ICI-treated patients: ⚠️ Only 46% got post-treatment thyroid labs 🔍 Among those

DESTINY-Breast09: Trastuzumab Deruxtecan Plus Pertuzumab Sets New First-Line Benchmark in HER2-Positive Metastatic Breast Cancer dailynews.ascopubs.org/do/destiny-bre… @asco #asco25 gilberto lopes

#ASCO25 🫁Lung Cancer Orals: #IMforte Ph3 Maintenance #Lurbinectedin+ Atezolizumab in ES- SCLC 🎙️Luis Paz-Ares 🔹PFS 5.4 vs 2.1 mos (HR 0.54) 🔹mOS from randomized 13.2 vs 10.6m (HR 0.57) ⬆️ AEs Hematological 👉🏽New SOC 1L maintenance lurbi+atezo for ES-SCLC (at some extra

#ASCO25 Honored to be invited to speak at the Pan American Cancer Consortia with oncology leaders from LATAM, Canada and US to find solutions to improve MultiDisciplinaryTeam capabilities and collaborations across nations via technology and expertise sharing organized by

🫁 Happening now at #ASCO25: Eric K. Singhi, MD is delivering an insightful presentation on ASCO highlights in lung cancer and unpacking the key data that we've seen during this meeting, don't miss this! ➡️ Find #lcsm news from here: buff.ly/dqYkpql #NSCLC #SCLC

📢 The 🟰 #EQUAL study presented at #ASCO25 by #FlorezLab is redefining who gets screened for lung 🫁 cancer. Using blood-based EGFR ctDNA testing in Latinx & East/Southeast Asian 🌏 nonsmokers, this trial is paving a path toward equity in early detection. 🧬🩸 🧪 Over 60% of

3 of 5 OncLive.com #LungCancer Fellows’ Forum faculty w/ our awesome hats! Don’t worry Sandip Patel MD FASCO- I have one for you too! Benjamin Levy Narjust Florez, MD, FASCO Eric K. Singhi, MD Kristen A. Marrone, MD #ASCO25

EQUAL Study Redefines Lung Cancer Screening for Nonsmokers - Abner Antonio Murray, MD PhD #FlorezLab oncodaily.com/url/307561 #OncoDaily #Oncology #Cancer #Health #Medicine #LungCancerScreening

Watch for the next episode of the IASLC podcast, Lung Cancer Considered, for #ASCO25 highlights. Dr. Narjust Florez, MD, FASCO and I discuss the most impactful studies from ASCO with Dr. Patrick Forde and Dr. Charu Aggarwal, MD, MPH, FASCO. Be sure to listen!

#RapidUpdates from #ASCO25! This is a must listen quick update in #LungCancer w/ Stephen V Liu, MD Narjust Florez, MD, FASCO Patrick Forde IASLC ASCO Penn Medicine - Abramson Cancer Center

Missed the first deadline? No worries, #OncologyFellows! You've got a second chance to submit your #LungCancer abstract. The new deadline is June 20th! Don't miss out on Huntington Beach this July. Solange Peters Narjust Florez, MD, FASCO Tony Mok Apply: hubs.li/Q03qLTN00

🚨 Early bird registration for #WCLC25 ends TODAY! Don’t miss your chance to save on the world’s largest lung cancer conference. 📍 Barcelona | 📅 Sept. 6–9, 2025 Secure your spot NOW: wclc.iaslc.org/registration/ #IASLC #LungCancer #GlobalOncology #CancerCare #OncologyConference